D. Calligaris

发表

Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma

S. Pastorino, I. Tsigelny, S. Kesari, 2015, Oncotarget.

Profiling of adrenocorticotropic hormone and arginine vasopressin in human pituitary gland and tumor thin tissue sections using droplet-based liquid-microjunction surface-sampling-HPLC–ESI-MS–MS

S. Santagata, D. Calligaris, N. Agar, 2015, Analytical and Bioanalytical Chemistry.

Mass spectrometry imaging as a tool for surgical decision-making.

F. Jolesz, A. Golby, I. Norton, 2013, Journal of mass spectrometry : JMS.

Mass spectrometry imaging is moving toward drug protein co-localization.

D. Calligaris, D. Lafitte, C. Villard, 2012, Trends in biotechnology.

Advances in Molecular Imaging for Surgery

F. Jolesz, O. Olubiyi, D. Calligaris, 2015 .

First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development.

M. Cima, R. Langer, S. Pomeroy, 2016, Journal of biomedical nanotechnology.

Rapid discrimination of pediatric brain tumors by mass spectrometry imaging

T. MacDonald, D. P. Pomeranz Krummel, S. Pomeroy, 2018, Journal of Neuro-Oncology.

MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation

I. Norton, O. Olubiyi, I. Dunn, 2015, Proceedings of the National Academy of Sciences.

Towards Lipidomics of Low-Abundant Species for Exploring Tumor Heterogeneity Guided by High-Resolution Mass Spectrometry Imaging

E. De Pauw, J. Cimino, D. Calligaris, 2013, International journal of molecular sciences.

The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma

J. Sarkaria, B. Ma, J. Eckel-Passow, 2015, Clinical Cancer Research.

Chemical inhibitors: the challenge of finding the right target.

D. Calligaris, D. Lafitte, 2011, Chemistry and Biology.

Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis

Isaiah Norton, Ferenc A Jolesz, Sandro Santagata, 2014, Proceedings of the National Academy of Sciences.

InhibitorRucaparib inOrthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System

J. Sarkaria, J. Sludden, A. Boddy, 2015 .

Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma.

P. Sharp, Monica Stanciu, M. Yaffe, 2017, Cancer cell.

Tubulin isoforms identified in the brain by MALDI in-source decay.

S. Granjeaud, O. Chinot, D. Figarella-Branger, 2013, Journal of proteomics.

Ultraviolet laser induced hydrogen transfer reaction: study of the first step of MALDI in-source decay mass spectrometry.

N. Smargiasso, E. De Pauw, D. Calligaris, 2013, The journal of physical chemistry. B.

Tyrosine-dependent capture of CAP-Gly domain-containing proteins in complex mixture by EB1 C-terminal peptidic probes.

M. Steinmetz, B. Monsarrat, D. Calligaris, 2012, Journal of proteomics.

Multiplatform Metabolomics Studies of Human Cancers With NMR and Mass Spectrometry Imaging

Leo L. Cheng, Jeffery N Agar, M. Mino‐Kenudson, 2022, Frontiers in Molecular Biosciences.

Selected protein monitoring in histological sections by targeted MALDI-FTICR in-source decay imaging.

A. Noël, R. Longuespée, E. De Pauw, 2013, Analytical chemistry.

Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents

Nathalie Y. R. Agar, Justin M. Wolfe, Colin M. Fadzen, 2017, Nature Communications.

A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas

W. Hahn, L. Garraway, K. Ligon, 2017, Neuro-oncology.

Rapid Mass Spectrometry Imaging to Assess the Biochemical Profile of Pituitary Tissue for Potential Intraoperative Usage.

I. Dunn, S. Santagata, D. Calligaris, 2017, Advances in cancer research.

Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System

J. Sarkaria, J. Sludden, A. Boddy, 2015, Molecular Cancer Therapeutics.

EfficacyofPARP InhibitorRucaparib inOrthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System

J. Sarkaria, J. Sludden, J. Murray, 2015 .

Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery

Isaiah Norton, Ferenc A Jolesz, Sandro Santagata, 2014, Proceedings of the National Academy of Sciences.

Label-Free Neurosurgical Pathology with Stimulated Raman Imaging.

Isaiah Norton, Sandro Santagata, Alexandra J Golby, 2016, Cancer research.

Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal.

G. Mazzucchelli, E. De Pauw, J. Cimino, 2014, Cell metabolism.

Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma

Elizabeth C. Randall, Aaron J. Johnson, Kristina B. Emdal, 2018, Nature Communications.

Quantitative proteomic analysis to decipher the differential apoptotic response of bortezomib‐treated APL cells before and after retinoic acid differentiation reveals involvement of protein toxicity mechanisms

Odile Burlet-Schiltz, David Bouyssié, Bernard Monsarrat, 2013, Proteomics.

Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery

Elizabeth C. Randall, Sankha S. Basu, I. Norton, 2021, NPJ breast cancer.

Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma

Elizabeth C. Randall, Aaron J. Johnson, Kristina B. Emdal, 2018, Nature Communications.

Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain Barrier

Aaron J. Johnson, J. Sarkaria, J. Watters, 2018, Molecular Cancer Therapeutics.

In-source decay during matrix-assisted laser desorption/ionization combined with the collisional process in an FTICR mass spectrometer.

Tyler A. Zimmerman, E. De Pauw, D. Calligaris, 2013, Analytical chemistry.

MALDI in-source decay of high mass protein isoforms: application to alpha- and beta-tubulin variants.

D. Calligaris, D. Braguer, D. Lafitte, 2010, Analytical chemistry.

Molecular typing of Meningiomas by Desorption Electrospray Ionization Mass Spectrometry Imaging for Surgical Decision-Making.

P. Brastianos, I. Norton, I. Dunn, 2015, International journal of mass spectrometry.

Advances in top-down proteomics for disease biomarker discovery.

Claude Villard, D. Calligaris, D. Lafitte, 2011, Journal of proteomics.

Microtubule targeting agents: from biophysics to proteomics

C. Villard, D. Braguer, D. Calligaris, 2010, Cellular and Molecular Life Sciences.

Matrix-assisted laser desorption/ionization mass spectrometry and Raman spectroscopy: An interesting complementary approach for lipid detection in biological tissues

R. Longuespée, E. Pauw, C. Malherbe, 2014 .